Aroa Biosurgery

Mangere, New Zealand Founded: 2008 • Age: 18 yrs
Developer of medical and surgical products for soft tissue reconstruction
Request Access

About Aroa Biosurgery

Aroa Biosurgery is a company based in Mangere (New Zealand) founded in 2008.. Aroa Biosurgery operates in a competitive market with competitors including Humacyte, Kerecis, Miach Orthopaedics, CUTISS and Rotation Medical, among others.

  • Headquarter Mangere, New Zealand
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aroa Biosurgery Limited
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Medical Devices & Diagnostics
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $47.76 M (USD)
    20.43
    as on Mar 31, 2024
  • Net Profit
    $-2.15 M (USD)
    64.77
    as on Mar 31, 2024
  • EBITDA
    $531.16 K (USD)
    111.65
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Aroa Biosurgery

Aroa Biosurgery is a publicly listed company on the ASX with ticker symbol ARX in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: ASX · Ticker: ARX . Sector: Health technology · Australia

Funding Insights of Aroa Biosurgery

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Aroa Biosurgery

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aroa Biosurgery

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aroa Biosurgery Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aroa Biosurgery

Aroa Biosurgery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Humacyte, Kerecis, Miach Orthopaedics, CUTISS and Rotation Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Human tissue-based products are developed for vascular disease applications.
domain founded_year HQ Location
Fish-skin acellular dermal matrix technology is provided for wound treatments.
domain founded_year HQ Location
Bio-engineered surgical implants for connective tissue repair are developed.
domain founded_year HQ Location
Personalized skin tissue therapy is developed by CUTISS for surgeries.
domain founded_year HQ Location
A rotator cuff repair system is developed for disease treatment.
domain founded_year HQ Location
Soft tissue reconstruction solutions for knee and shoulder
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aroa Biosurgery

Frequently Asked Questions about Aroa Biosurgery

When was Aroa Biosurgery founded?

Aroa Biosurgery was founded in 2008.

Where is Aroa Biosurgery located?

Aroa Biosurgery is headquartered in Mangere, New Zealand.

What is the annual revenue of Aroa Biosurgery?

Annual revenue of Aroa Biosurgery is $47.76M as on Mar 31, 2024.

What does Aroa Biosurgery do?

Aroa Biosurgery was founded in 2008 in Mangere, New Zealand, and operates in the medical and surgical sector. Proprietary AROA ECM technology is utilized to create extracellular matrix biomaterials derived from ovine forestomach. These materials support wound healing and soft tissue reconstruction. Key products include Endoform, Myriad Matrix, Myriad Morcells, and Reinforced Bioscaffold, which are applied in clinical settings for tissue repair.

Who are the top competitors of Aroa Biosurgery?

Aroa Biosurgery's top competitors include Humacyte, Kerecis and CUTISS.

Is Aroa Biosurgery publicly traded?

Yes, Aroa Biosurgery is publicly traded on ASX under the ticker symbol ARX.

What is Aroa Biosurgery's ticker symbol?

The ticker symbol of Aroa Biosurgery is ARX on ASX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available